Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Australia's Immuron rises on diarrhoea drug application in U.S.

** Shares of biopharma co Immuron Ltd  IMC.AX  up 3.8% at
A$0.083, their highest since Nov. 16
    ** Co says submitted an investigational new drug application
to U.S. FDA for travelan, an oral immunotherapeutic drug for
treatment of gut-mediated diseases
    ** Shares mark their biggest intraday pct gain since Nov. 28
    ** Over 110,600 shares traded vs 30-day avg of ~98,350
    ** Stock down 20% this year, as of last close, vs a 1.92%
decline in the benchmark S&P/ASX 200 index  .AXJO 
 (Reporting by Roushni Nair in Bengaluru)
 ((Roushni.Nair@thomsonreuters.com;))

Recent news on Immuron

See all news